ArticleFrontiers in immunology2022

m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent.

Jianqiu Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.